Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide
GLP-1 receptor agonists are a class of diabetes medicines offering self-regulating glycemic efficacy and may best be administrated in long-acting forms. Among GLP-1 receptor agonists, exenatide is the one requiring the least dose so that controlled-release poly(<span style="font-variant: small-caps"...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI AG
2021-05-01
|
| Σειρά: | Pharmaceutics |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.mdpi.com/1999-4923/13/6/816 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|